Koninklijke Philips (PHG) Change in Working Capital (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Change in Working Capital came in at -$128.8 million in Q1 2026, up 43.32% year-on-year from -$89.9 million in Q1 2025, and down 121.4% quarter-over-quarter from $601.8 million in Q4 2025.
Koninklijke Philips (PHG) Change in Working Capital (2009 - 2026) Analysis & Trends
Koninklijke Philips' Change in Working Capital history runs 18 years deep, the most recent figure standing at -$128.8 million for Q1 2026.
- On a quarterly basis, Change in Working Capital rose 43.32% year-over-year to -$128.8 million in Q1 2026; TTM through Mar 2026 was -$297.6 million, a 73.73% increase from a year earlier, with the FY2025 full-year figure at $30.3 million, down 92.02% from the prior year.
- Change in Working Capital eased to -$128.8 million in Q1 2026 per PHG's latest filing, from $601.8 million in the prior quarter.
- Across five years, Change in Working Capital topped out at $982.3 million in Q4 2023 and bottomed at -$1.3 billion in Q3 2024.
- The 5-year median for Change in Working Capital is -$227.2 million (2025), against an average of -$198.0 million.
- Across the five-year window, Change in Working Capital soared 211.7% in 2023 and sank 205.37% in 2024, its largest moves.
- Year by year, Change in Working Capital stood at -$879.5 million in 2022, then surged by 211.7% to $982.3 million in 2023, then decreased by 13.52% to $849.5 million in 2024, then retreated by 29.16% to $601.8 million in 2025, then plunged by 121.4% to -$128.8 million in 2026.
- Per Business Quant, the three latest PHG Change in Working Capital figures stand at -$128.8 million (Q1 2026), $601.8 million (Q4 2025), and -$633.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -128.78 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.78 Mn |
| Mar 31, 2026 | -128.78 Mn |
| Dec 31, 2025 | 601.81 Mn |
| Dec 31, 2025 | 601.81 Mn |
| Sep 30, 2025 | -633.63 Mn |
| Sep 30, 2025 | -633.63 Mn |
| Jun 30, 2025 | -136.97 Mn |
| Jun 30, 2025 | -136.97 Mn |
| Mar 31, 2025 | -227.21 Mn |
| Mar 31, 2025 | -227.21 Mn |
| Dec 31, 2024 | 849.53 Mn |
| Dec 31, 2024 | 849.53 Mn |
| Sep 30, 2024 | -1.26 Bn |
| Sep 30, 2024 | -1.26 Bn |
| Jun 30, 2024 | -492.14 Mn |
| Jun 30, 2024 | -492.14 Mn |
| Mar 31, 2024 | -571.43 Mn |
| Mar 31, 2024 | -571.43 Mn |
| Dec 31, 2023 | 982.33 Mn |
| Dec 31, 2023 | 982.33 Mn |